Flu season can definitely be considered a corporate concern.
The Sunday, September 5 edition of The Washington Post included an article about ongoing efforts to improve medication adherence through research and patient-focused strategies.
The Story: On Tuesday, Democratic presidential nominee Hillary Clinton rolled out a plan to lower prescription drug prices. The plan switches the debate from the Affordable Care Act and focuses more on middle class concerns surrounding the rising price of medications.
Now that flu season is approaching, health experts held a news conference in Washington, D.C., stating that this year’s vaccine has been updated and should do a much better job at fighting the flu than last season’s.
Generation Z takes in information instantaneously...and loses interest just as fast.
The Story: Following a protracted battle, on September 15 Vermont became the final state to allow e-prescribing for all controlled substances, including Schedule II painkillers such as oxycodone, hydrocodone and morphine. This is an important step forward in the fight against prescription fraud and drug abuse.
The Pharmacy and Medically Underserved Areas Enhancement Act would take our healthcare system to the next level...